To see PCC's position on PSA testing, click here.

June 2012

New Ways to Target Androgens in Prostate Cancer

June 21, 2012

Prostate cancer cells require androgens including testosterone to grow. A recent review in the British Journal of Urology International describes new classes of drugs that target androgens in novel ways, providing alternatives to the traditional methods that frequently carry high side effects. Read more.

Read the article or watch the video →

Continuous vs. Intermittent ADT Therapy

June 18, 2012

Dr. Myers talks about continuous versus intermittent ADT for PCa. Click here to view.

Read the article or watch the video →

June 2012 Newsletter

June 6, 2012

The June 2012 Newsletter is available by clicking here Some of the content: Wake Up call Breakfast Dr. Uri Lindner at July 25, 2012 Scotiabank Awareness Night Two Dieticians speaks at March Scotiabank Awareness Night Dr. Singal speaks at May Scotiabank Awareness Night Meet Philip Ng PCCN Conference – Regina Words from Ken Hunter PCCN-Toronto […]

Read the article or watch the video →

Raduim-223 Drug Beneficial for Bone Metatasis Patients

June 6, 2012

Treatment with the investigational drug radium-223 (Alpharadin) is associated with significantly increased overall survival in patients with castration-resistant prostate cancer (CRPC), researchers reported at the American Society of Clinical Oncology 2012 annual meeting. Read More.

Read the article or watch the video →

Cancer on the Brain – Cancer Phobia

June 5, 2012

I got a call from a friend last year. He had prostate cancer and wanted some help thinking through what to do. He had gone to his doctors for the details about his physical condition. He was calling me for help dealing with the other condition he knew he was facing — excessive fear of […]

Read the article or watch the video →

Survival Better with Continuous ADT

June 4, 2012

CHICAGO—Intermittent androgen deprivation therapy (ADT) has some quality-of-life (QOL) benefits for men with metastatic prostate cancer (PCa), but overall survival times are inferior to those seen with continuous ADT, according to the findings of a 17-year study (SWOG9346) presented at the American Society for Clinical Oncology 2012 annual meeting. Read More

Read the article or watch the video →

Protein Marker for Aggressive Prostate Cancer

June 1, 2012

Prostate cancer protein discovered by scientists could lead to new tests and  treatments *  The protein is found in aggressive forms of the cancer *  Scientist believe they can use the protein as a marker, providing a potential new target for drug treatment Read More  

Read the article or watch the video →

Focal HIFU

June 1, 2012

It is hoped the new treatment, which involves heating only the tumours with a highly focused ultrasound, will mean men can be treated without an overnight stay in hospital and avoiding the distressing side effects associated with current therapies. Read more.

Read the article or watch the video →